Supply Chain Director for Cell & Gene Therapy Products, GSK

Chris Baldwin is the Supply Chain Director for Cell & Gene Therapy Products at GSK and is accountable for the vein to vein supply chain for T-Cell Immuno-Oncology products covering a network of apheresis collection centers, manufacturing sites and treatment centers. His team covers forecasting processes, logistics, labelling, Chain of Identity tracking, site on-boarding and coordinating the cellular supply chain across sites for clinical supply and building the strategy for commercial supply. In previous roles, he has lead teams to design and build supply chains for complex biological products including mRNA vaccines, Biosimilars and Antibody Drug Conjugates. Chris holds a PhD from University of Cambridge and a Masters from University College, London.